The Central Drug Standards Control Organization (CDSCO) has taken an important step towards strengthening transparency in drug safety by introducing a new dedicated link for its monthly alerts on drugs classified as “Not of Standard Quality” (NSQ). The notice regarding this update was duly issued on August 28, 2025.
This initiative is designed to offer stakeholders with faster, easier and more reliable access to important information that was previously scattered in several parts of the CDSCO website.
Easier Access to Drug Safety Information
Until now, monthly NSQ alerts were published on the CDSCO website but were not easy to appreciate for the general public or professionals seeking particular details. The new link streamlines the procedure by providing a user-friendly interface where one can search for product name, manufacturing details, and information associated to NSQ results.
By making this change, CDSCO aims to guarantee that vital safety updates are available to everyone, whether they are health care professionals, pharmaceutical companies or patients. This proactive approach demonstrates the regulator’s commitment to establishing accountability and transparency in the pharmaceutical region.
Why the Move Matters for Stakeholders
For health care professionals, time to time access to NSQ alerts means they can make better-informed decisions about patient treatment and prevent substandard medicines. On the other hand, manufacturers gain more clarity on compliance requirements and can quickly address quality concerns. Most significantly, patients and the general public can now directly authenticate information related to drug safety through the official portal of CDSCO.
The launch of this link also supports the government’s wider vision of reinforcing public health protections in India. With more seamless access, stakeholders are motivated to stay up to date on drug standards and play their part in safeguarding patient safety.
The new dedicated link for NSQ drug alerts can be accessed here: https://cdsco.gov.in/opencms/opencms/en/Notifications/nsq-drugs/
By centralizing this information, CDSCO took a significant step towards enabling the public with reliable information. Going forward, stakeholders are expected to take maximum advantage of this feature to stay up-to-date on the latest updates in drug safety.
This portion of the site is for informational purposes only. The content is not legal advice. The statements and opinions are the expression of author, not corpseed, and have not been evaluated by corpseed for accuracy, completeness, or changes in the law.
